Thriving in COVID-19 with flexible marketing strategiesPharma sales is set to change forever. To keep afloat in the current climate, teams need to embrace Share XThriving in COVID-19 with flexible marketing strategieshttps://deep-dive.pharmaphorum.com/magazine/digital-health-innovation-2020/thriving-in-covid-19-with-flexible-marketing-strategies/
Syneos Health bolsters healthcare communications leadershipSyneos Health has made a series of senior appointments to the leadership of its communications business under new Share XSyneos Health bolsters healthcare communications leadershiphttps://pharmaphorum.com/news/syneos-health-cassidy-tender-dorrian/
ASCO 2020: Scientific advances & what’s impacting doctors and patientsDespite going virtual due to the COVID-19 pandemic, Jennifer Harris, an immuno-oncology expert from Syneos Health told pharmaphorum’s Share XASCO 2020: Scientific advances & what’s impacting doctors and patientshttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/asco-2020-scientific-advances-and-the-impact-on-doctors-and-patients/
Syneos Health invests in Microsoft/Indegene platformBiopharma services company Syneos Health has taken a minority stake in Indegene Omnipresence, a partnership between life sciences Share XSyneos Health invests in Microsoft/Indegene platformhttps://pharmaphorum.com/news/syneos-health-microsoft-indegene-life-sciences-platform/
Boosting trial recruitment through patient engagementImproving clinical trial recruitment has long been a priority for pharma, but despite having a plethora of new Share XBoosting trial recruitment through patient engagementhttps://deep-dive.pharmaphorum.com/magazine/patient-engagement/boosting-trial-recruitment-through-patient-engagement-syneos/
15 pharma trends for 2020Real world evidence, patient centricity and new digital experiences are among the top 15 trends set to change Share X15 pharma trends for 2020https://pharmaphorum.com/views-analysis-digital/15-pharma-trends-for-2020/
Finding the right value propositionWith health technology assessment organisations becoming more powerful in Europe, and huge public scrutiny on drug prices in Share XFinding the right value propositionhttps://deep-dive.pharmaphorum.com/magazine/sales-and-marketing-2019/finding-the-right-value-proposition-syneos-health/
Join the dots or lose out, Syneos Health advises big pharmaPharma companies need to rethink how they communicate and share information and insights within their own organisations, according Share XJoin the dots or lose out, Syneos Health advises big pharmahttps://pharmaphorum.com/views-analysis-sales-marketing/join-the-dots-or-lose-out-syneos-health-advises-big-pharma/
eyeforpharma barcelona day twoDay two: Wednesday 13 March Highlights include: John Zibert, chief medical officer of LEO Innovation Lab, on being Share Xeyeforpharma barcelona day twohttps://pharmaphorum.com/views-and-analysis/eyeforpharma-barcelona-day-two/
